Literature DB >> 20980871

Raltegravir-induced cerebellar ataxia.

Kim A Reiss, Justin R Bailey, Paul A Pham, Joel E Gallant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20980871     DOI： 10.1097/QAD.0b013e32833fca42

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Ataxia and HIV: clinicopathologic correlations in a case of HIV-associated cerebellar leukoencephalopathy.

Authors:  Christos Ganos; Christian Bernreuther; Jakob Matschke; Christian Gerloff; Alexander Münchau; Frank Leypoldt
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

Review 2.  HIV integrase inhibitors: 20-year landmark and challenges.

Authors:  Mathieu Métifiot; Christophe Marchand; Yves Pommier
Journal:  Adv Pharmacol       Date:  2013

3.  Magnetic resonance imaging findings in patients presenting with (sub)acute cerebellar ataxia.

Authors:  Tanja Schneider; Götz Thomalla; Einar Goebell; Anna Piotrowski; David Mark Yousem
Journal:  Neuroradiology       Date:  2015-02-17       Impact factor: 2.804

4.  96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience.

Authors:  Amedeo Capetti; Simona Landonio; Paola Meraviglia; Antonio Di Biagio; Sergio Lo Caputo; Gaetana Sterrantino; Adriana Ammassari; Barbara Menzaghi; Marco Franzetti; Giuseppe Vittorio De Socio; Giovanni Pellicanò; Elena Mazzotta; Alessandro Soria; Marianna Meschiari; Michele Trezzi; Lolita Sasset; Benedetto Maurizio Celesia; Patrizia Zucchi; Sara Melzi; Elena Ricci; Giuliano Rizzardini
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

5.  An HIV-infected Patient with No Serious Adverse Events after Overdosing on Raltegravir.

Authors:  Tomohiro Hosoda; Yuki Uehara; Toshio Naito
Journal:  Intern Med       Date:  2019-09-18       Impact factor: 1.271
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.